SENTRY
The National Drug Intelligence Center (NDIC) SENTRY is an Internet-based
system designed to collect and disseminate synthetic drug-related
data in order to identify new trends at an early stage, evaluate
their likely importance, and track their development.
SENTRY
focuses on synthetic drugs that are primarily produced via a
chemical process, such as LSD (lysergic acid diethylamide),
MDMA (3,4-methylenedioxymethamphetamine, also known as ecstasy),
and methamphetamine. To be truly effective as an early warning
system, however, the system also monitors prescription drugs,
over-the-counter medications, botanical substances and extracts,
and chemicals and products involved in the manufacturing of
synthetic drugs.
SENTRY is accessible via the NDIC Internet site. From the SENTRY
web site, authorized users can submit information on a new or
unusual synthetic drug-related activity via an electronic submission
form, link to partner agencies and our listserv, search and
receive NDIC products, and view previously reported submissions
using the geographic information system capabilities.
SENTRY welcomes partnerships at multiple levels--federal, state,
and local. Current partners include the Office of National Drug
Control Policy (ONDCP), Substance Abuse and Mental Health Services
Administration, and National Institute on Drug Abuse. In addition,
a network of correctional officers, drug diversion investigators,
emergency medical personnel, forensic chemists, juvenile detention
officers, law enforcement officers, medical toxicologists, school
nurses, school resource officers, and treatment providers have
joined the SENTRY partnership.
NDIC uses the information obtained through SENTRY, combines it
with additional information, and produces and disseminates Drug
Alert Watch and Drug Alert Warning reports. A Drug Alert Watch
report is issued when a pattern of synthetic drug-related activity
is first identified. The Drug Alert Watch report relies heavily
on qualitative information obtained from our wide network of
partners. Once a pattern is established, NDIC continues collecting
and evaluating additional information.
When a trend is detected, a Drug Alert Warning is issued. A Drug
Alert Warning combines the qualitative data collected in the
Drug Alert Watch phase with quantitative data collected by NDIC
analysts and our partners.
SENTRY is operated by NDIC in coordination with ONDCP and supports
the National Synthetic Drugs Action Plan.
How to Participate
To participate in SENTRY and report emerging synthetic
drug-related issues in your area, please provide the
following information, typed on your agency letterhead, and
fax it to (814) 532-5858:
- Contact information including:
- Name and title of requestor
- Requestor's role within your agency; please
choose only one
- Chemist
- Education provider (teacher,
administrator, school resource officer,
school nurse)
- Law enforcement officer
- Treatment provider to include
physicians specializing in drug abuse
issues
- Medical service personnel (physician,
nurse, emergency medical technician,
medical examiner)
- Other, please explain
- Complete mailing address (do not use post office
box numbers)
- E-mail address
- Phone number
- Fax number
- Signature of requestor
Submitters agree to be contacted to validate information.
An NDIC analyst will phone you within 5 business days
with your log-in information. The NDIC reserves the
right to verify the identity of the registrants and to
deny access to SENTRY.
Any release of SENTRY information beyond this community
is not authorized without the prior written authority
of NDIC. Unauthorized releases of SENTRY information
may result in the termination of the offending user or
agency/organization’s access to the SENTRY system.
To
Top
More Information
For more information on NDIC or SENTRY, contact:
Collections Management Group
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Telephone: (814) 532-5888
FAX: (814) 532-5858
NDIC publications are available on the following web sites:
Internet: ww.usdoj.gov/ndic
ADNET: http://ndicosa
RISS: ndic.riss.net
LEO:
https://www.leo.gov/http://leowcs.leopriv.gov/lesig/ndic/index.htm
NDIC is a component of the U.S. Department of Justice and is
located in Johnstown, Pennsylvania. The NDIC mission is to
provide strategic drug-related intelligence and assistance
to the drug control, public health, and national security
authorities of the United States in order to reduce the
adverse impact of drug trafficking, drug abuse, and related
harms to the United States.
To
Top
|